Recovery · In Clinical Trials
Body Protection Compound (BPC) Variants
No lawful US pathway
01 · Overview
BPC-157 is a 15-amino acid peptide representing a partial sequence of body protection compound, a protein isolated from human gastric juice (PMID 21030672). It is proposed to have gastroprotective, angiogenic, and tissue repair properties; preclinical studies suggest it increases growth hormone receptor expression and pathways involved in cell growth and angiogenesis while reducing inflammatory cytokines (PMID 40756949).
Its receptor targets remain undefined.
02 · Research summary & key findings
A 2025 systematic review of musculoskeletal research found 35 preclinical studies and only one clinical study, with animal models showing improved healing of muscle, tendon, ligament, and bone injuries; in a retrospective human study, 7 of 12 patients reported knee pain relief after injection (PMID 40756949). Other human reports are small uncontrolled pilots, including a two-person intravenous safety study (PMID 40131143) and a 12-patient interstitial cystitis series (PMID 39325560); a 2026 review noted fewer than 30 human subjects in total and no completed phase II trial (PMID 42198317). BPC-157 is not FDA approved, and randomized trials are now registered.
03 · Regulatory status
Body Protection Compound (BPC) Variants is currently undergoing clinical trials. It is not yet FDA-approved and is available only through clinical research settings or investigational protocols.
No lawful pathway today
Body Protection Compound (BPC) Variants is not FDA-approved and does not currently have a lawful prescription or compounding pathway in the United States, so we do not sell it and will not book a consultation for it. That can change: in 2026 FDA began reviewing several peptides for compounding. If you are working on the goal it is studied for, a licensed clinician can tell you what is lawfully available, which may be something else.
See the 3 FDA-approved compounds in Recovery
Tell me if the status changes
One email, only if this compound's regulatory standing actually moves. Not a newsletter, not a sales sequence.
Looking for a lawful, clinician-prescribed option for injury recovery and tissue repair?
Body Protection Compound (BPC) Variants is still in clinical trials, is not FDA-approved, and has no lawful US compounding pathway, so we do not offer it and no clinician we work with will prescribe it. Products sold online as “research chemicals” are not made or tested to the standards required of medicines. If you are working on injury recovery and tissue repair, a licensed clinician can tell you at a free consultation whether an FDA-approved or lawfully compounded treatment fits you, or whether nothing does.
Explore lawful options (free intake)About 3 minutes. If a protocol is prescribed through our provider, we earn 10% of the sale. See the receipts.
04 · Administration routes
- Subcutaneous injection
- Oral
References
- [1]The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration J Appl Physiol (1985), 2011. PMID 21030672
- [2]Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study Altern Ther Health Med, 2024. PMID 39325560
- [3]Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study Altern Ther Health Med, 2025. PMID 40131143
- [4]Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review HSS J, 2025. PMID 40756949
- [5]BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Pharmaceutics, 2026. PMID 42198317
Primary literature
- PubMed: "Body Protection Compound Variants"
Peer-reviewed literature indexed by the National Library of Medicine.
- ClinicalTrials.gov: "Body Protection Compound Variants"
Registered interventional and observational studies, including status and phase.
- PubChem: "Body Protection Compound Variants"
Chemical structure, molecular properties, and bioactivity data.
Related peptides in Recovery
Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol. See our editorial policy for how this content is produced and reviewed. Clinicians: join the network.